Named on one round in the feed.
Since 2025-09-03
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Galvanize Therapeutics Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-09-03 | [ PART ] |
No sector on record.